How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies

Abe Dunn, Lasanthi Fernando and Eli Liebman

BEA Papers from Bureau of Economic Analysis

Abstract: Medical innovation is a key driver of cost growth and improved life expectancy, but measuring the welfare contribution of innovations is challenging. We leverage thousands of medical studies to estimate the quality of treatments for 13 health conditions and combine these estimates with insurance claims data to quantify how innovations diffuse and their impact on costs and quality. Across nearly all conditions we study, we find higher quality innovations diffuse. Like markets outside of healthcare, we find innovations can improve consumer welfare substantially. However, we also observe a phenomena arguably unique to healthcare, cases where innovation reduces consumer welfare.

JEL-codes: E31 I10 O30 (search for similar items in EconPapers)
Date: 2024-12
New Economics Papers: this item is included in nep-hea and nep-ino
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.bea.gov/system/files/papers/BEA-WP2024-8.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bea:papers:0132

Access Statistics for this paper

More papers in BEA Papers from Bureau of Economic Analysis Contact information at EDIRC.
Bibliographic data for series maintained by Andrea Batch ().